ferroptosis has been proposed to be involved in COVID-19-related brain injury (Zhang et al., 2022)
Rybelsus is a once-a-day tablet licensed only for type 2 diabetes, where it leads to more modest weight loss of around 4 kg (4-5%)
While these conversations often come from good intentions, they can spread partial or misleading information especially about safety, dosing, or who these medications are meant for. Some people may hear that GLP-1s are too risky for older adults, while others are told theyre a universal solution for aging or weight management
That early characterization remains a frequent reference point for labs designing comparative secretagogue protocols today
Over the past decade, there has been a substantial increase in GLP-1RA use, and some research has highlighted its gastrointestinal side effects
The FDA's evolving stance on compounded GLP-1 medications is an ongoing consideration